Analysis on the Effect and Safety of Baihe Wuyao Xiexin Decoction in Treating Reflux Esophagitis

To analyze the efficacy and safety of Baihe Wu Yao Xiexin Decoction in the treatment of reflux esophagitis. Methods: A total of 80 patients with reflux esophagitis were selected from June 2021 to June 2023. Patients were randomly divided into a observation group, with 40 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Baihe Wuyao Xiexin Decoction. The therapeutic effect, TCM symptom score and adverse reactions were compared between the two groups. Results: In terms of treatment effect, the total effective rate of observation group was 97.50% higher than that of control group (80.00%), P < 0.05. In terms of TCM symptom score, the observation group had heartburn (0.89±0.20) score, acid reflux (0.79±0.17) score, constipation (0.67±0.14) score, dry mouth and bitter mouth (0.77±0.19) score, emotional distress (0.73±0.13) score, and pain in the two hypochasm (0.84±0.15) score. They were lower than (1.00±0.25) points, (0.90±0.21) points, (0.78±0.17) points, (0.87±0.18) points, (0.83±0.19) points and (0.95±0.23) points in the control group, respectively, P < 0.05. In terms of adverse reactions, the total incidence of 5.00% in the observation group was lower than 25.00% in the control group (P < 0.05). Conclusion: In the treatment of reflux esophagitis, the use of Baihe Wu drug Xiexin decoction can improve the total effective rate, alleviate symptoms, reduce adverse reactions, the effect and safety are very ideal.